Department of Pharmacy, Anhui No.2 Provincial People's Hospital, Hefei, 230041, People's Republic of China.
Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410008, People's Republic of China.
Clin Exp Med. 2023 Sep;23(5):1425-1440. doi: 10.1007/s10238-022-00947-5. Epub 2022 Dec 9.
Long non-coding RNAs play important roles in cellular functions and disease development. H19, as a long non-coding RNA, is pervasively over-expressed in almost all kinds of human malignant tumors. Although many studies have reported that H19 is closely associated with tumor cell proliferation, apoptosis, invasion, metastasis, and chemoresistance, the role and mechanism of H19 in gene regulation and tumor development are largely unclear. In this review, we summarized the recent progress in the study of the major functions and mechanisms of H19 lncRNA in cancer development and progression. H19 possesses both oncogenic and tumor-suppressing activities, presumably through regulating target gene transcription, mRNA stability and splicing, and competitive inhibition of endogenous RNA degradation. Studies indicate that H19 may involve in cell proliferation and apoptosis, tumor initiation, migration, invasion, metastasis and chemoresistance and may serve as a potential biomarker for early diagnosis, prognosis, and novel molecular target for cancer therapy.
长非编码 RNA 在细胞功能和疾病发展中发挥重要作用。H19 作为一种长非编码 RNA,几乎在所有人类恶性肿瘤中都过度表达。尽管许多研究报道 H19 与肿瘤细胞增殖、凋亡、侵袭、转移和化疗耐药密切相关,但 H19 在基因调控和肿瘤发生中的作用和机制在很大程度上尚不清楚。在这篇综述中,我们总结了 H19 lncRNA 在癌症发生和发展过程中的主要功能和机制的最新研究进展。H19 具有致癌和抑癌活性,可能通过调节靶基因转录、mRNA 稳定性和剪接以及竞争性抑制内源性 RNA 降解来实现。研究表明,H19 可能参与细胞增殖和凋亡、肿瘤起始、迁移、侵袭、转移和化疗耐药,并可能作为早期诊断、预后和癌症治疗新的分子靶点的潜在生物标志物。